Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
D000328:Adult; D000713:Anastomosis, Roux-en-Y; D001786:Blood Glucose / Q000502:physiology; D002096:C-Peptide / Q000097:blood / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D005260:Female; D015390:Gastric Bypass / Q000379:methods*; D005749:Gastric Inhibitory Polypeptide / Q000097:blood / Q000502:physiology; D005768:Gastrointestinal Hormones / Q000097:blood / Q000502:physiology*; D005934:Glucagon / Q000097:blood / Q000502:physiology; D052216:Glucagon-Like Peptide 1; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000502:physiology; D007328:Insulin / Q000097:blood / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000097:blood / Q000150:complications / Q000503:physiopathology* / Q000601:surgery*; D010446:Peptide Fragments / Q000097:blood / Q000502:physiology; D011498:Protein Precursors / Q000097:blood / Q000502:physiology
D001786:Blood Glucose; D002096:C-Peptide; D005768:Gastrointestinal Hormones; D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D006854:Hydrocortisone